Modification Agreement - Patent Schedule No. 002

MODIFICATION AGREEMENT


This Modification Agreement (the "Agreement") is entered into this 10TH day of FEBRUARY, 1998 and is effective as of NOVEMBER 1, 1997 by and between American BioMed, Inc. ("ABI") and Cathlab Corporation and Aberlyn Capital Management Limited Partnership ("Aberlyn").


Reference is made to that certain Patent Assignment and License Agreement NO. 0001P dated DECEMBER 31, 1992, as modified, and Patent Schedule NO. 002 dated JUNE 1, 1996 (the "Contract") by and between American BioMed, Inc. and Cathlab Corporation (the "Licensee") and Aberlyn Capital Management Limited Partnership or its' assignee (the "Company")


For good and valuable consideration, receipt of which is hereby acknowledged, the Contract, and all documents executed in connection therewith, are hereby modified as follows:


1. Patent Schedule NO. 002 to the Patent Assignment and License Agreement:


A. The Base Royalty section under Schedule B is hereby modified as follows:


FROM: TO:


Royalty Payment Royalty Payment Royalty Payment Royalty Payment - --------------- --------------- --------------- ---------------
Nos. Amount Nos. Amount
---- ------ ---- ------ ...